Immatics Biotechnologies GmbH - Regulatory Unbefristete Anstellungen München

[20.08.2024] -- Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep knowhow is the foundation for our pipeline of...